ALLIANCEBERNSTEIN L.P. - ROCKET PHARMACEUTICALS INC ownership

ROCKET PHARMACEUTICALS INC's ticker is RCKT and the CUSIP is 77313F106. A total of 154 filers reported holding ROCKET PHARMACEUTICALS INC in Q2 2021. The put-call ratio across all filers is 0.82 and the average weighting 0.4%.

Quarter-by-quarter ownership
ALLIANCEBERNSTEIN L.P. ownership history of ROCKET PHARMACEUTICALS INC
ValueSharesWeighting
Q3 2023$2,594,075
+5.4%
126,602
+2.2%
0.00%0.0%
Q2 2023$2,462,092
-17.9%
123,910
-29.2%
0.00%0.0%
Q1 2023$2,998,110
+213.3%
175,021
+257.9%
0.00%
Q4 2022$956,973
+22.7%
48,9000.0%0.00%
Q3 2022$780,000
-65.6%
48,900
-70.3%
0.00%
-100.0%
Q2 2022$2,269,000
+15.5%
164,889
+33.1%
0.00%0.0%
Q1 2022$1,965,000
-37.4%
123,900
-13.8%
0.00%0.0%
Q4 2021$3,139,000
-29.2%
143,812
-3.0%
0.00%
-50.0%
Q3 2021$4,432,000
+82.5%
148,272
+170.3%
0.00%
+100.0%
Q2 2021$2,429,000
+12.2%
54,847
+12.4%
0.00%0.0%
Q1 2021$2,165,000
-17.7%
48,800
+1.7%
0.00%0.0%
Q4 2020$2,632,000
+229.0%
48,000
+37.1%
0.00%
Q3 2020$800,000
+5.0%
35,000
-3.8%
0.00%
Q2 2020$762,000
+56.1%
36,400
+4.0%
0.00%
Q1 2020$488,000
-42.7%
35,000
-6.4%
0.00%
Q4 2019$851,000
+76.9%
37,400
-9.4%
0.00%
Q3 2019$481,000
+4.1%
41,300
+34.1%
0.00%
Q2 2019$462,000
+9.0%
30,800
+27.3%
0.00%
Q1 2019$424,000
+41.8%
24,200
+19.8%
0.00%
Q4 2018$299,000
-19.6%
20,200
+33.8%
0.00%
Q3 2018$372,000
-68.4%
15,100
-74.8%
0.00%
-100.0%
Q2 2018$1,176,00059,9000.00%
Other shareholders
ROCKET PHARMACEUTICALS INC shareholders Q2 2021
NameSharesValueWeighting ↓
M28 Capital Management LP 665,880$10,627,00011.09%
RTW INVESTMENTS, LP 15,802,802$252,213,0005.82%
Ally Bridge Group (NY) LLC 479,506$7,653,0005.05%
TANG CAPITAL MANAGEMENT LLC 1,265,900$20,204,0002.48%
TIGER MANAGEMENT L.L.C. 279,700$4,464,0001.95%
Prosight Management, LP 200,000$3,192,0001.71%
COWEN AND COMPANY, LLC 999,588$15,953,0001.53%
Boxer Capital, LLC 1,466,051$23,398,0001.32%
Affinity Asset Advisors, LLC 267,794$4,274,0001.19%
HARBOR CAPITAL ADVISORS, INC. 66,410$1,060,0000.97%
View complete list of ROCKET PHARMACEUTICALS INC shareholders